Tecan

Professor Christophe Deben runs the Tumoroid Screening Lab at the University of Antwerp. His team screens patient-derived organoids at scale with automated imaging combined with AI-driven drug discovery. The result: A first-in-class cancer drug candidate. Register for the live webinar on Nov 16 to hear how they did it. Monday, November 16 at 16:00 GMT | 17:00 CET | 11:00 EST | 08:00 PST Register for free today.

Couple of months on from ADLM in Anaheim, I’ve had time to reflect on what I saw and heard. What struck me most was not what was new. It was what was familiar. Walking the show floor, I saw Tecan’s technology inside some of the major innovations shaping clinical diagnostics today. It was a reminder of how much of our work happens behind the scenes, alongside customers developing products that ultimately reach laboratories around the world. That kind of presence is not something you can simply claim. It is earned through years of development partnerships that go well beyond the initial contract. The conversations I had at ADLM confirmed something I have believed for a long time. IVD and Life Sciences companies do not just want a supplier; they want a partner who understands the whole journey and how decisions at one stage can affect what comes next. I also noticed that more players are starting to tell a similar story: end-to-end support, full lifecycle capabilities and similar concepts. The language is converging. But language is not capability. What matters is the evidence behind it: systems in the field, products manufactured at scale, relationships built over years, and teams that understand what it takes to move a complex product from concept to commercialization. ADLM was a good reminder of what Tecan has already built, and of the opportunity ahead. What did you take away from ADLM this year? #ADLM2026 #IVD #LifeSciences #TecanPartnering #Diagnostics

Moving to animal-free endotoxin testing takes more than a new kit. Tecan's pyrogen detection packages pair the Infinite 200 reader with Magellan assay templates and automated quality check tools, so you can transition without disrupting QC operations. Click below to learn more.

Modernize your endotoxin testing workflow with animal-free alternatives and pre-configured solutions that save time, lower costs, and support sustainability. Tecan's flexible platforms support both established LAL methods and next-generation recombinant factor assays. Click below to learn more.

From LAL to rFC to MAT, Tecan's open platform runs kits from leading vendors on one reader, so you can pick the assay that best fits your scientific, operational and QC needs. Click below to learn more.

When manual prep becomes the bottleneck, throughput stops being a platform problem and starts being a people problem. Automating proteomics sample prep on Fluent® gives your team back two days of bench work every week and raises sample throughput by 30%, with runs that continue outside working hours. Click below to learn more.